Maxim Jacobs, CFA

VP, Investor Relations and Corporate Communications

Maxim Jacobs, CFA, brings more than 20 years of experience to his role. Most recently, he was Senior Vice President and head of the Investor Relations group at Russo Partners, a public and investor relations firm focused on healthcare. Previously, he served as Vice President of Investor Relations at Avalo Therapeutics. Prior to that, Max was Managing Partner and Director of Research for North America for Edison Group, a global investment research, investor relations and consulting firm. He also led two primary market research teams as Director of Survey and Tracker Research at Guidepoint, a leading expert network. Earlier in his career, Max spent a decade managing and leading investments in the healthcare sector for several institutions, including Broadfin, Ridgemark, Mehta Partners, and Trilogy Advisors.

Max earned a bachelor’s degree in economics, magna cum laude, from the University of Pennsylvania. He is also a CFA Charterholder.

Carol Vallone

Chair of the Board of Directors, Chair of Compensation Committee, Member of Audit/Finance Committee

Andreas Krebs

Vice Chair of the Board of Directors, Chair of Nomination and Governance Committee, Member of Audit/Finance Committee

David Gryska

Board Director, Chair of Audit Committee

Roger Crystal, MD

Board Director, Member of Nomination & Governance Committee, Member of Compensation Committee

Robert Barrow

Chief Executive Officer and Board Director

Suzanne Bruhn, PhD

Board Director, Member of Nomination & Governance Committee, Member of Compensation Committee

Schond Greenway, MBA

Chief Financial Officer

Miri Halperin Wernli, PhD

Executive President

Daniel Karlin, MD, MA

Chief Medical Officer

Mark Sullivan, JD

Chief Legal Officer and Corporate Secretary

Francois Lilienthal, MD, MBA

Chief Commercial Officer

Carrie Liao, CPA

Chief Accounting Officer

Robert Silva, PhD

VP, Head of Development

Bridget Walton, MS

VP, Global Regulatory Affairs

Maxim Jacobs, CFA

VP, Investor Relations and Corporate Communications

Robert Malenka, MD, PhD

Chairman of the Scientific Advisory Board, Nancy Friend Pritzker Professor in Psychiatry and Behavioral Sciences at Stanford University

Peter Bergethon, MD

Member, Scientific Advisory Board VP, Head of Quantitative & Clinical Technologies, Biogen, Inc.

Robert Dworkin, PhD

Professor of Anesthesiology and Perioperative Medicine, Neurology, and Psychiatry at University of Rochester

Maurizio Fava, MD

Psychiatrist-in-Chief of the Massachusetts General Hospital (MGH)

Carole Abel, MBA

VP, Programs and Portfolio Office (PPO)

Peter Mack, PhD

VP, Pharmaceutical Development

Corklin Steinhart, MD, PhD

VP, Global Medical Affairs

Phong Duong, PharmD

VP, Global Market Access

Maria Oquendo, MD, PhD

Ruth Meltzer Professor and Chairman of Psychiatry at University of Pennsylvania, Psychiatrist-in-Chief at the Hospital of the University of Pennsylvania

Matthias Liechti, MD, PhD

Scientific Collaborator & Advisor

Kim PC Kuypers, PhD

Scientific Collaborator & Advisor

Peter Gasser, MD

Clinical Advisor